1. Introduction to Investigator Oversight
An Investigator Oversight Plan is a formal document that outlines how a principal investigator (PI) will supervise and oversee clinical trial activities at their site. It ensures protection of study subjects, data quality, and regulatory compliance throughout the trial lifecycle.
Key elements typically include: delegation of duties, supervision procedures, training requirements, and monitoring of compliance with the protocol and regulatory requirements.
2. Does the FDA Provide a Template?
No. The FDA does not provide a ready-made template for the Investigator Oversight Plan. Instead, the FDA issues guidance documents describing regulatory expectations while leaving format and structure to each site or institution.
3. FDA Guidance Documents
While the FDA does not provide a template, two key guidance documents outline the expectations for investigator oversight:
- Guidance for Industry: Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects
https://www.fda.gov/media/77765/download
This guidance states that investigators "should develop a plan for the supervision and oversight of the clinical trial at the site." - Guidance for Industry: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/oversight-clinical-investigations-risk-based-approach-monitoring
This assists in developing risk-based monitoring strategies and oversight plans focused on human subject protection and data quality.
4. Institutional Templates Available
Several institutions have publicly shared their Investigator Oversight Plans or equivalent SOPs that can serve as reference models:
- SCRS (Society for Clinical Research Sites) — Principal Investigator Oversight
https://myscrs.org/wp-content/uploads/2020/03/Principal-Investigator-oversight.docx - UH Bristol NHS Foundation Trust — Investigator Oversight of Research
https://www.uhbristol.nhs.uk/media/3940779/sop_008_investigator_oversight_of_research_uhbw_v3.0_17.08.22.pdf - LSU Health Sciences Center — Principal Investigator Oversight
https://www.lsuhsc.edu/administration/academic/ors/clinicaltrials/docs/SOP%202.01(a)%20Principal%20Investigator%20Oversight-signed.pdf - IDCRC (Infectious Diseases Clinical Research Consortium) — Study Oversight
https://idcrc.org/_includes/documents/idcrc_mop_section14_studyoversight_v1.0_12oct20221.pdf - VCU Health — Investigator Responsibilities
https://cctr.vcu.edu/media/cctr/images/support/clinical-research-sops/CR-AD-105InvestigatorResponsibilities.pdf - University of Utah — Investigator Oversight SOP
https://qualitycompliance.research.utah.edu/sop-library/uu-sop-04.php - University of Florida — PI Responsibilities and Oversight
https://cancer.ufl.edu/wordpress/files/2025/08/PI-Responsibilities-and-Oversight.pdf - UNC (University of North Carolina) — PI Supervisory Plan Template
https://research.unc.edu/wp-content/uploads/2025/01/CRCO_Template_PI_Supervisory_Plan_2024.12.18.docx
These templates can serve as valuable reference models when developing your own site-specific Investigator Oversight Plan. Use FDA guidance documents as the content framework and institutional SOPs as structural models.
